Drug Profile
Heptazyme
Alternative Names: Hepatitis C virus ribozyme; LY 466700Latest Information Update: 08 Jan 2008
Price :
$50
*
At a glance
- Originator Sirna Therapeutics
- Class Antivirals; Ribozymes
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C